300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Costa Rica
Colombia
China
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Paraguay
Moldova
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Philippines
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in South Korea (October 2026)

The most active venture capital funds investing in South Korea Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in South Korea Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Dayli Partners
VC Fund
32 South Korea, United States, Indonesia Series A, Series B, Seed Biotechnology, Health Care, Medical $791k–$29M
Korea Investment Partners
VC Fund
24 South Korea, United States, China Series A, Series B, Seed Biotechnology, Health Care, Information Technology $973k–$50M
KB Investment
VC Fund
20 South Korea, United States, Vietnam Series A, Seed, Series B Software, Artificial Intelligence, Biotechnology $737k–$44M
Company K Partners
VC Fund
19 South Korea, United States, Singapore Series A, Venture - Series Unknown, Series B Biotechnology, Health Care, Artificial Intelligence $1.7M–$42M
Industrial Bank of Korea
VC Fund
17 South Korea, United States, China Series A, Series B, Seed Artificial Intelligence, Information Technology, Software $166k–$28M
Mirae Asset Venture Investment
VC Fund
14 South Korea, United States, India Series A, Series B, Seed Software, Artificial Intelligence, Biotechnology $692k–$52M
LSK Investment
VC Fund
13 South Korea, United States Series A, Series B, Series C Biotechnology, Medical, Health Care $1.6M–$46M
InfoBank
VC Fund
13 South Korea, South Africa, United States Seed, Series A, Series B Artificial Intelligence, Information Technology, Software $85k–$16M
STIC Ventures
VC Fund
12 South Korea, United States, Vietnam Venture - Series Unknown, Series A, Series B Biotechnology, Software, Information Technology $2M–$47M
Aju IB Investment
VC Fund
12 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Therapeutics
UTC Investment Co.
VC Fund
12 South Korea, United States, Japan Series A, Venture - Series Unknown, Series B Biotechnology, Health Care, Medical $500k–$21M
Medytox Venture Investment
VC Fund
12 South Korea Series A, Series B, Seed Biotechnology, Pharmaceutical, Medical $4k–$44M
Partners Investment
VC Fund
12 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Software $2.4M–$98M
Magna Investment
VC Fund
11 South Korea, United States, Japan Seed, Series A, Series B Health Care, Biotechnology, Pharmaceutical $147k–$18M
Kolon Investment
VC Fund
11 South Korea, India, Indonesia Series A, Series B, Seed Biotechnology, Software, Artificial Intelligence $1.2M–$24M
Devsisters Ventures
VC Fund
10 South Korea, United States, Russian Federation Venture - Series Unknown, Series A, Seed Software, Biotechnology, Gaming $441k–$11M
Future Science and Technology Holdings
VC Fund
10 South Korea, United States Seed, Series A Biotechnology, Health Care, Information Technology $231k–$6.7M
Timepolio Asset Management
VC Fund
10 South Korea, United States, Russian Federation Series B, Series A, Series C Biotechnology, Health Care, Manufacturing $3.4M–$80M
Series Ventures
VC Fund
9 South Korea, Singapore Seed, Series A, Venture - Series Unknown Health Care, Manufacturing, Biotechnology $86k–$4.4M
Atinum Partners
VC Fund
9 South Korea, United States, Singapore Series A, Series B, Series C Software, Biotechnology, Artificial Intelligence $3M–$40M
DSC Investment
VC Fund
9 South Korea, United States, Israel Series A, Series B, Seed Artificial Intelligence, Health Care, Biotechnology $594k–$60M
Korea Technology Finance
VC Fund
9 South Korea, Russian Federation Seed, Series A, Series B Software, Health Care, Manufacturing $383k–$15M
Korea Credit Guarantee Fund
VC Fund
9 South Korea, United States, China Seed, Series A, Venture - Series Unknown Artificial Intelligence, Information Technology, Software $229k–$15M
IMM Investment
VC Fund
9 South Korea, United States, Japan Venture - Series Unknown, Series A, Series B Biotechnology, Health Care, Software $1.3M–$78M
HB Investment
VC Fund
9 South Korea, United States, Vietnam Venture - Series Unknown, Series B, Series A Software, Biotechnology, Artificial Intelligence $941k–$25M
KB Securities
VC Fund
9 South Korea, United States, China Series B, Series A, Venture - Series Unknown Software, Artificial Intelligence, Information Technology $1.5M–$35M
Enlight Ventures
VC Fund
9 South Korea, Indonesia, United States Seed, Series A, Series B Manufacturing, Information Technology, Artificial Intelligence $94k–$20M
Shinhan Capital
VC Fund
9 South Korea, United States, India Series A, Seed, Series B Information Technology, Software, E-Commerce $424k–$20M
SJ Investment Partners
VC Fund
8 South Korea, United States, Hong Kong Series A, Series B, Seed Biotechnology, Manufacturing, Medical $547k–$27M
Innopolis Partners
VC Fund
8 South Korea, United States, United Kingdom Venture - Series Unknown, Series A Manufacturing, Biotechnology, Health Care $1M–$13M
Timewise Investment
VC Fund
8 South Korea, United States, Russian Federation Series A, Series B, Seed Biotechnology, Health Care, Information Technology $981k–$29M
Korea Development Bank
VC Fund
7 South Korea, United States, Japan Series B, Series A, Series C Artificial Intelligence, Software, Information Technology $1.9M–$51M
Hana Ventures
VC Fund
7 South Korea, United States, Indonesia Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Health Care $273k–$13M
Dt& Investment
VC Fund
7 South Korea, Vietnam, United States Series B, Series A, Seed Biotechnology, E-Commerce, Medical $81k–$18M
Stick Ventures
VC Fund
7 South Korea, United States Series B, Series A, Series C Biotechnology, Artificial Intelligence, Health Care $2.3M–$122M
Stonebridge Ventures
VC Fund
7 South Korea, United States, Japan Series A, Series B, Seed Artificial Intelligence, Biotechnology, Software $1M–$17M
HG Initiative
VC Fund
7 South Korea, United States Series A, Seed, Series B Biotechnology, Health Care, Medical $360k–$13M
Kiwoom Investment
VC Fund
7 South Korea, United States, Japan Series B, Series A, Series C Information Technology, Software, Artificial Intelligence $1.7M–$33M
BSK Investment
VC Fund
7 South Korea Series A, Series B, Series C Biotechnology, Software, Health Care $2.1M–$57M
Premier Partners
VC Fund
7 South Korea, United States, Russian Federation Venture - Series Unknown, Series B, Series A Health Care, Biotechnology, Medical $2.6M–$172M
Smilegate Investment
VC Fund
7 South Korea, United States, Vietnam Seed, Series A, Series B Artificial Intelligence, Software, Health Care $694k–$47M
L&S Venture Capital
VC Fund
6 South Korea, United States, Israel Series A, Series B, Seed Manufacturing, Information Technology, Software $692k–$39M
Pathfinder H
VC Fund
6 South Korea Series A, Series B, Seed E-Commerce, Biotechnology, Artificial Intelligence $775k–$21M
ActnerLab
VC Fund
6 South Korea, United States, Japan Seed, Venture - Series Unknown Health Care, Medical, Medical Device $37k–$84k
Coolidge Corner Investment
VC Fund
6 South Korea, United States, Belgium Seed, Series A, Series B Software, Health Care, Manufacturing $223k–$14M
POSCO CAPITAL
VC Fund
6 South Korea, United States Series A, Seed, Series B Software, Manufacturing, Information Technology $171k–$14M
Shinhan Venture Investment
VC Fund
6 South Korea, United States, India Venture - Series Unknown, Series B, Series A Manufacturing, Health Care, Software $1.7M–$78M
Stone Bridge Ventures
VC Fund
6 South Korea, United States, South Africa Seed, Series A, Series B Artificial Intelligence, Software, Information Technology $1.6M–$22M
Kakao Ventures
VC Fund
6 South Korea, United States, Indonesia Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $280k–$27M
Capstone Partners
VC Fund
6 South Korea, United States, India Series A, Seed, Series B Software, Mobile, Artificial Intelligence $223k–$17M
Access all 723 VC funds in South Korea Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Dayli Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 32 investments in South Korea Biotechnology startups

Dayli Partners is an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Indonesia

Investor stats

  • Total investments: 116
  • Round size: Seed $791k–$6.7M; Series A $847k–$17M; Series B $1.5M–$29M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • SureTech — Suretech is an AI insurtech firm, operates the Carsure platform, which automates the automotive insurance claims process from accident reporting to repair shop matching, cost estimation, and settlement.
  • Hyundai Heavy Industries Power Systems — Hyundai Heavy Industries Power Systems designs and manufactures heat recovery steam generators and boilers for commercial clients. The company provides heat recovery steam generator (HRSG) boilers, power generating and industrial boilers, circulating fluidized bed (CFBC) boilers, and ancillary equipment, allowing clients to create custom-made generators and boilers based on their operational
Show all investments...

Korea Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 24 investments in South Korea Biotechnology startups

Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YG Entertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 539
  • Round size: Seed $973k–$10M; Series A $2.2M–$19M; Series B $4.9M–$50M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $60M in 2023

Portfolio highlights

  • Zamface — Zamface is an app that makes beauty video.
  • Wakebunny — Wakebunny is a company that specializes in IP-based commerce, leveraging intellectual property to create, market, and monetize unique products and experiences. By focusing on the strategic use of copyrights, trademarks, and brand assets, Wakebunny transforms original ideas, characters, and stories into commercially viable offerings across variousplatforms such as e-commerce, digital media, merchandising, and licensing.
  • Inovio Pharmaceuticals — INOVIO is advancing novel immunotherapy technologies to reshape the future of treating and preventing infectious diseases and cancer.
Show all investments...

KB Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 20 investments in South Korea Biotechnology startups

Founded in 1990, KB Investment Co., Ltd. (KBIC) is one of Korea’s leading investment firms of venture capital and private equity funds with over USD 2.6 Billion of asset under management as of December 2023. KBIC is a subsidiary of KB Financial Group, Korea’s premier financial group with the largest domestic customer base as well as the widest network of service branches in Korea. KBIC’s team is recognized for industry thought leadership, a broad network of powerful industry relationships, and a unique professional investment approach to investing. KBIC passionately support our portfolio companies with active guidance in all key aspects of team building, strategy, operations and governance

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 440
  • Round size: Seed $737k–$7.2M; Series A $2.5M–$36M; Series B $5.2M–$44M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • H&B Asia — H&B Asia specializes in sourcing, importing, and distributing fresh fruits and agricultural products. The company works closely with global growers and suppliers to bring high-quality produce into the Korean market. It focuses on building strong partnerships, ensuring consistent supply, and supporting efficient logistics across the fooddistribution value chain.
  • GMI Cloud — Run production AI workloads on GMI Cloud. Deploy serverless inference, dedicated GPU clusters, and bare metal AI infrastructure on one scalable platform.
  • ACT-ion Battery Technologies — ACT-ion Battery Technologies is a manufacturing company that offers cathode active materials for lithium batteries.
Show all investments...

Company K Partners
VC Fund · Ilsangu, Seoul-t'ukpyolsi, South Korea · 19 investments in South Korea Biotechnology startups, 15 in the past 12 months

Company K Partners Limited is a principal investment firm specializing in investments in culture content, electronic components, computer, machinery, broadcasting, arts, sports, and leisure industries. The firm primarily invests in South Korea with a focus in Seoul, Gyeongnam, and Gyeonggi. Company K Partners Limited was established in 2006 and is based in Gyeonggi-do, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 243
  • Round size: Series A $1.7M–$17M; Series B $5.1M–$42M; Venture - Series Unknown $2.8M–$30M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • RX — RX is a startup that provides an on-site analysis solution for material properties, mainly serving environment, energy, inspection, and testing needs. It also develops technology related to next-generation nuclear power plants and agentic AI, supported by national R&D activity.This company helps industries assess materials and engineeringconditions more efficiently and accurately.
  • Turing — Reinvent Education with Technology
  • KaliVir Immunotherapeutics — multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer. LEARN MORE NEWS AND EVENTSAugust 19, 2026 - KaliVir Immunotherapeutics Announces Closing of $14 Million Series A Extension Financing READ MORE November 19, 2025 - KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate
Show all investments...

Industrial Bank of Korea
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 17 investments in South Korea Biotechnology startups

Industrial Bank of Korea (IBK) is committed to honoring its charter of financing small and medium sized enterprises (SMEs). The Bank has extended the scope of its expertise to provide a comprehensive range of financial services to individual customers in a quest to emerge as a leading financial services group. In pursuit of that goal, IBK is making every effort to enhance its competitiveness, achieve balanced growth and strengthen its global presence. The Bank employs around 10,000 staff and operates a distribution network of 612 branches including 12 overseas branches. Providing complementary services, the Bank also operates several subsidiaries: IBK Capital Corporation, IBK-SG Asset Management, IBK System Co., Ltd., and IBK Credit Information Corporation. In 2008, IBK Investment & Securities was launched, focused on meeting the needs of SME customers for services such as IPOs and M&As. Moreover, strategic alliance with Korea Investment Holdings enhances product competitiveness and affiliation with the National Post Office promoting easy customer access to IBK banking services.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 316
  • Round size: Seed $166k–$4.5M; Series A $2.3M–$17M; Series B $4.8M–$28M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • BIGC — BIGC is a technology company that offers digital marketing, content creation, and advertising services.
  • Hurotics — Hurotics is a company with deep-tech technology related to human-robot fusion.Hurotix's wearable robots, notably the 'H-Flex', are modular and give personalized support based on the user's demands, assisting users in overcoming physical restrictions.
  • Airbility — Airability is a developer for potential airline mobility solutions.
Show all investments...

Mirae Asset Venture Investment
VC Fund · Seongnam, Kyonggi-do, South Korea · 14 investments in South Korea Biotechnology startups

A fundamental investment philosophy of ‘Building on principles’ guides us at Mirae Asset. Over the years, these principles have enabled us to become Asia’s premier financial group and created new trends in the Asian capital market. Above all, we put our clients’ interests first, always adhering to high ethical standards. Because our success clearly comes from their success, we use fundamental investment principles to identify opportunities that generate value and lasting profits. We are strong believers in teamwork and are determined to recruit the best and brightest people as we open new horizons in Asia and expand globally. Just as we strive to continually improve our own performance, Mirae Asset is committed to helping every community it joins. On behalf of the entire Mirae Asset Financial Group, I would like to convey the sense of responsibility your trust in us merits and pledge to do all that we can to exceed your expectations.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 341
  • Round size: Seed $692k–$14M; Series A $2M–$40M; Series B $5M–$52M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely actively investing — fresh fund, raised $118M in 2026

Portfolio highlights

  • Hurotics — Hurotics is a company with deep-tech technology related to human-robot fusion.Hurotix's wearable robots, notably the 'H-Flex', are modular and give personalized support based on the user's demands, assisting users in overcoming physical restrictions.
  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
Show all investments...

LSK Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 13 investments in South Korea Biotechnology startups

LSK Investment is a Korean venture capital firm that provides long-term capital and management support to venture enterprises. The firm was founded in 2016 and is based in Seoul, Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States

Investor stats

  • Total investments: 45
  • Round size: Series A $1.6M–$14M; Series B $8.3M–$16M; Series C $3.2M–$46M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — raised $15M in 2022

Portfolio highlights

  • Trioar — Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.
  • MBD — MBD is a biotechnology company that specializes in 3D cell culture platforms.
  • IMBiologics — IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules.
Show all investments...

InfoBank
VC Fund · Gyeongju, Kyongsang-bukto, South Korea · 13 investments in South Korea Biotechnology startups

InfoBank develops and provides mobile messaging solutions and other related services.The company offers business messaging services such as SMS, LMS, and multimedia message services; interactive media services; smart car solutions; and integrated online and offline payment services.InfoBank was founded in 1995 and is based in Gyeongju, SouthKorea.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, South Africa, United States

Investor stats

  • Total investments: 166
  • Round size: Seed $85k–$1.5M; Series A $88k–$9.4M; Series B $8M–$16M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Pmatch — Pmatch is a comprehensive platform designed to provide reliable, accurate medication information to help users make informed decisions about their healthcare. By offering detailed insights into various medications, including their uses, dosages, side effects, and interactions, Pmatch ensures that individuals can use medicines in a smarter and saferway. The platform aims to enhance patient safety, reduce medication errors, and improve overall health outcomes by empowering users with the knowledge they need to manage their treatments effectively. Whether for healthcare professionals or patients, Pmatch serves as a trusted resource for promoting informed decision-making and better health management.
  • A2D2 — A2D2 AI analyzes and organizes tens of thousands of pages of evidence documents.
  • Limpid — Limpid is a Bio pet food startup. It set new standards in pet nutrition through continuous innovation.
Show all investments...

STIC Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 12 investments in South Korea Biotechnology startups

STIC Ventures invests in small and mid-sized venture companies with core technologies and new business models.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Information Technology
  • Stage:Venture - Series Unknown, Series A, Series B
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 159
  • Round size: Series A $2M–$44M; Series B $8.8M–$47M; Venture - Series Unknown $3.7M–$17M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — raised $172M in 2013

Portfolio highlights

  • Liner — LINER is Asia’s first AI Agent that helps users accomplish more with less time and effort “AI Workspace”, known as the autonomous agent, performs various and complex tasks requested by users using LLM-based AI, differentiated by LINER’s highlighter database. More than 94% of LINER's users are from outside Korea & more than 100 countries.We are reducing our customer’s research time from hundreds of minutes to tens of seconds every day with our product.
  • Enhans — Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services.
  • Pebble Square — Pebble Square's new Processing-In-Memory (PIM) architecture is a significant advancement for AI performance and power efficiency.
Show all investments...

Aju IB Investment
VC Fund · Yeoksamdong, Seoul-t'ukpyolsi, South Korea · 12 investments in South Korea Biotechnology startups

Aju IB Investment is a venture capital firm that offers SMEs with investments and consulting services.Aju IB Investment offers consulting services that focus on business management, tax, accounting, legal, mergers and acquisitions, additional funding, marketing, and technology support.Aju IB Investment was founded in September 1974 and is basedin Seoul, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 106
  • Lead/follow: no public data

Portfolio highlights

  • Gangnam Unni — Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medicalinformation and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries.The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases.As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
  • Healing Paper — Healing Paper is a mobile healthcare and information technology company.
  • Kovis Technology — Kovis Technology is a manufacturer of measurement and inspection equipment intended for global semiconductor and electronic industries.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
UTC Investment Co.
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 12 investments in South Korea Biotechnology startups

Since its incorporation in 1988, UTC Investment has been implementing and developing private equity investments with deep roots in buyout area, diversified human resources, and an impressive track record as a leading global investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 131
  • Round size: Series A $2.3M–$13M; Series B $4.9M–$21M; Venture - Series Unknown $500k–$12M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Beamworks — Beamworks is a research-centered company in medical imaging and conversational AI, that enables expert-level cancer diagnosis anywhere in the world and providing reliable medical consultations at any time. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for serverconnectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures.
  • CanLab — CanLab is a developer of AI sensors that focuses on creating optical and thermal cameras, as well as real-time image processing platforms for ground, aerial, and marine mobility. Its product offerings include the Vision Camera, Edge AI Platform, Equipment for Thermal Cameras, and Automotive Camera MES.
  • AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
Show all investments...

Medytox Venture Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 12 investments in South Korea Biotechnology startups

Medytox Venture Investment is a TIPS operator that provides opportunities and supports growth in the healthcare sector.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 23
  • Round size: Seed $3M–$3.4M; Series A $3.4M–$15M; Series B $4k–$44M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Nex Eye — Nex Eye is an innovative biotechnology firm that offers revolutionary immunotherapy solutions for individuals battling cancer. The company addresses the fundamental reasons behind the failure of immunotherapy, which are influenced by the biology of cancer itself. Utilizing its ON-SMRT® platform based on actual patient data and resistant cancermodels, Nex Eye identifies new immune-evasion targets such as ONCOKINE®. By transforming the approach to tackling immune resistance, the firm is pioneering a new era in cancer therapy by revitalizing the capabilities of the immune system.
  • Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
  • Inventera Pharmaceuticals — Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.
Show all investments...

Partners Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 12 investments in South Korea Biotechnology startups, 7 in the past 12 months

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 132
  • Round size: Series A $2.4M–$30M; Series B $5.5M–$98M; Series C $7.4M–$87M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — raised $190M in 2023

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Solivis — Solivis is the manufacturer of solid-state batteries designed for next-generation battery packs. The company's product is used as a secondary battery for electric vehicles and has developed a wet synthesis method that can mass-produce a sulfide-based solid electrolyte with homogeneous high ionic conductivity, enabling clients to significantlyimprove productivity by reducing process costs and shortening the synthesis time.
  • Cenyx Biotech — Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
Show all investments...

Magna Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 11 investments in South Korea Biotechnology startups

As a Venture Capital / Accelerator / Private Equity Manager specialized in initial companies, SMEs and SMEs, They are generating profits by finding and investing in companies with promising growth potential.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 99
  • Round size: Seed $147k–$3.1M; Series A $1.8M–$12M; Series B $3.8M–$18M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • ABLE Labs — ABLE Labs provide liquid handling robots and protocols so that all researchers can focus on constructing assay, leaving the execution to robots.​ If you want would contact them please contact them via phone call or email.
  • AIT STUDIO — AIT Studio is a digital health startup that develops AI-powered, contactless gait analysis solutions for early detection of mobility decline and age-related conditions such as sarcopenia. Our flagship products—GAIT Studio (App) and MediStep M Pro (hardware package)—deliver full gait assessments in under 1 minute, without wearables or specializedstaff.
  • Featuring — Featuring’s goal is to make it easy for anyone to see and utilize the power of influencers. Today, as companies are accelerating their transition to digital business due to COVID-19, the number of companies leveraging The number of influencers is explosively increasing. Featuring allows brands and marketers to discover product-fit influencers andhelps matching based on their needs. Currently, over 3,600 brands are using Featuring, and more than 8,500 influencer campaigns have been done. As a Korea-based startup, Featuring plans on expanding the business to Far East Asia, including Japan and China.
Show all investments...

Kolon Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 11 investments in South Korea Biotechnology startups, 12 in the past 12 months

Kolon Investment, Inc. is a venture capital and private equity firm specializing in buyouts, mezzanine, corporate restructuring, growth capital, and turnaround investment. It prefers to invest in electronic components, petroleum, energy, computer, and telecommunications equipment. The firm primarily invests in South Korea with a focus in Seoul, Gyeonggi, Incheon, and Gyeongbuk. Kolon Investment, Inc. was established in 2000 and is based in Seoul, South Korea. Source: Businessweek

Show more...

Investment focus

  • Industry: Biotechnology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, India, Indonesia

Investor stats

  • Total investments: 123
  • Round size: Seed $1.2M–$18M; Series A $2.4M–$11M; Series B $5.1M–$24M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
  • Bunker Kids — Bunker Kids is a startup that provides solutions optimized for achieving personal health goals using data and algorithms.
  • Turing — Reinvent Education with Technology
Show all investments...

Devsisters Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 10 investments in South Korea Biotechnology startups

Venture Capital firm in Korea. We are interested in early-stage investment in gaming, healthcare/biotech, IT services and high technology companies.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Gaming
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 109
  • Round size: Seed $441k–$3.5M; Series A $1.7M–$8.7M; Venture - Series Unknown $7.7M–$11M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — raised $23M in 2023

Portfolio highlights

  • Deeply — Deeply provides AI-powered sound analysis solutions for real-time monitoring across manufacturing, industrial safety, and security environments.
  • Red Brick House — Red Brick House is a specialized South Korean indie game publisher dedicated to discovering, supporting, and publishing innovative independent games, helping talented developers bring creative and engaging gaming experiences to players across domestic and global markets.
  • AWESOME Entertainment — AWESOME Entertainment is a media and digital content company that provides YouTube content production, influencer and MCN management, advertising and branded content creation, and media commerce services. The comapny supports brands with campaign planning, viral video production, and distribution across multiple social platforms, while alsooffering production outsourcing and partnership services to maximize audience reach and engagement.
Show all investments...

Future Science and Technology Holdings
VC Fund · Daejeon, Taejon-jikhalsi, South Korea · 10 investments in South Korea Biotechnology startups

Future Science and Technology Holdings is an investment company that specializes in technology-based services.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: South Korea, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $231k–$1.7M; Series A $2.2M–$6.7M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Apollon — Needle Gone, Data On
  • Protier Biotech — PROTIER Biotech is a company leading the development of therapeutics through innovative biotechnology .
  • ArcGen Bioscience — Embark on a Voyage in Immuno-Oncology
Show all investments...

Timepolio Asset Management
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 10 investments in South Korea Biotechnology startups, 7 in the past 12 months

Timepolio Asset Management is an asset management firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 87
  • Round size: Series A $3.4M–$17M; Series B $5.2M–$24M; Series C $10M–$80M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Enhans — Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services.
  • HEM Pharma — HEM Pharma is a biotechnology firm that focuses on personalized microbiome healthcare, live biotherapeutic drug (LBP) development, microbiome analysis, and health-functional food manufacturing. The company leverages proprietary microbiome technologies to develop individualized health solutions and next-generation microbiome-based therapeutics. andsupporting personalized microbiome solutions and functional nutrition products. HEM Pharma has expanded internationally through its Japanese subsidiary and global research partnerships.
  • Next Securities — The Next Generation AI-driven Brokerage Services
Show all investments...

Series Ventures
VC Fund · Changwon, Kyongsang-namdo, South Korea · 9 investments in South Korea Biotechnology startups

Series Ventures is an investment company for the beauty care, engineering, healthcare, social platform, and enterprise sectors.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: South Korea, Singapore

Investor stats

  • Total investments: 98
  • Round size: Seed $86k–$1.9M; Series A $2.9M–$4.4M
  • Lead/follow: 70% lead, 30% follow

Portfolio highlights

  • ROBOS — Robos is a hybrid robot system built by evaluating biological object vision data using Lidar Vision and Open CV-based Object Detection. By combining self-developed biomaterial machine vision technology and robot technology, it intends to expand into a company that delivers core services to diverse industrial sites such as manufacturing, food, andmedical.
  • With Doctors — With Doctors growth care solution precisely evaluates and analyzes physical, nutritional, psychological, and environmental factors affecting growth to derive the child's key management factors, and design and provide safe, scientifically proven, customized growth care programs for children through collaboration between exercise, nutrition, andpsychology experts and medical staff.
  • Golden Brain Care — Golden Brain Care develops "Brain Friends," an AI-powered platform designed for speech and cognitive rehabilitation targeting patients with neurological communication disorders. The platform digitizes the speech therapy lifecycle by integrating self-assessments, tailored vocal training, real-time performance data analysis, and guardianreporting mechanisms into a single workflow. Its core value proposition focuses on extending rehabilitation from clinical environments to daily life, bypassing limitations in face-to-face medical expert capacity through personalized home care systems.
Show all investments...

Atinum Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 9 investments in South Korea Biotechnology startups

Atinum Partners is a venture capital firm that invests in the growth stage startups in the IT, biotech, and healthcare sectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 193
  • Round size: Series A $3M–$24M; Series B $5.8M–$29M; Series C $12M–$40M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $596M in 2023

Portfolio highlights

  • Hurotics — Hurotics is a company with deep-tech technology related to human-robot fusion.Hurotix's wearable robots, notably the 'H-Flex', are modular and give personalized support based on the user's demands, assisting users in overcoming physical restrictions.
  • Liner — LINER is Asia’s first AI Agent that helps users accomplish more with less time and effort “AI Workspace”, known as the autonomous agent, performs various and complex tasks requested by users using LLM-based AI, differentiated by LINER’s highlighter database. More than 94% of LINER's users are from outside Korea & more than 100 countries.We are reducing our customer’s research time from hundreds of minutes to tens of seconds every day with our product.
  • Subtle Medical — Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant tofacilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
DSC Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 9 investments in South Korea Biotechnology startups, 14 in the past 12 months

DSC Investments invests in early stage and growth companies in the field of corporate identify and focus, IT, software, biotechnology, machinery, and future high-growth areas such as environment and resources.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Israel

Investor stats

  • Total investments: 264
  • Round size: Seed $594k–$9.1M; Series A $1.6M–$17M; Series B $4.8M–$60M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • OQT — OQT is focusing on developing QPUs utilizing neutral atoms.
  • IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
  • GMI Cloud — Run production AI workloads on GMI Cloud. Deploy serverless inference, dedicated GPU clusters, and bare metal AI infrastructure on one scalable platform.
Show all investments...

Korea Technology Finance
VC Fund · Busan, Pusan-jikhalsi, South Korea · 9 investments in South Korea Biotechnology startups, 9 in the past 12 months

Korea Technology Finance is a government-affiliated financial institution that supports technology-based startups and small and medium-sized enterprises (SMEs). Its services include technology appraisal, credit guarantees, equity investments, intellectual property protection, and technology transfer. Korea Technology Finance helps businesses access financing based on their technological capabilities and supports the commercialization of innovative technologies.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, Russian Federation

Investor stats

  • Total investments: 93
  • Round size: Seed $383k–$4.1M; Series A $1.8M–$8.4M; Series B $1.2M–$15M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Leecell — Leecell is a solar cell manufacturing company that produces organic and perovskite thin‑film photovoltaic cells.
  • K-Bio Gateway — K-Bio Gateway is a green bio healthcare startup specializing in the research and development of room temperature stable, anti obesity probiotics and functional microbiome materials. The company utilizes its proprietary DH24 functional probiotic strain to deliver weight-management solutions, serving both B2B functional material markets and B2C consumers
  • Unmanned Exploration Laboratory — Unmanned Exploration Laboratory manufactures multirotor drones, fixed-wing aircraft, and unmanned vehicles for space exploration.
Show all investments...

Korea Credit Guarantee Fund
VC Fund · Daegu, Taegu-jikhalsi, South Korea · 9 investments in South Korea Biotechnology startups

Korea Credit Guarantee Fund operates as a public financial institution.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 347
  • Round size: Seed $229k–$2.9M; Series A $881k–$7.8M; Venture - Series Unknown $884k–$15M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Limpid — Limpid is a Bio pet food startup. It set new standards in pet nutrition through continuous innovation.
  • DoubleT — DoubleT is an innovative tech enterprise specialized in industrial workplace safety and business automation. Its premier product, HEIMDALL, utilizes artificial intelligence and real-time location systems to prevent industrial accidents. They also operate DoubleWorks for corporate management and Jikguraound to streamline global B2B sourcing forbusinesses.
  • S-Innovations — S-Innovations is a robotics software company that develops SynK, a cyber-physical AI operating system for robot deployment, integration, and recovery across different robot brands and industrial facilities. The company provides automation software that enables faster robot setup, system connectivity, and operational management for sectors usingautonomous mobile robots
Show all investments...

IMM Investment
VC Fund · Kangnam, Cholla-namdo, South Korea · 9 investments in South Korea Biotechnology startups, 18 in the past 12 months

Korean alternative asset investment firm

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Venture - Series Unknown, Series A, Series B
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 327
  • Round size: Series A $2.6M–$46M; Series B $5.9M–$54M; Venture - Series Unknown $1.3M–$78M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely actively investing — fresh fund, raised $18M in 2026

Portfolio highlights

  • Enhans — Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services.
  • SK Horizon — SK Horizon is an AI data center (AIDC) infrastructure company whose name reflects its ambition to “open new horizons” in the AIDC sector, will be responsible for expanding its infrastructure to a total capacity of 318 MW, encompassing eight data centers already in operation - Seocho, Ilsan (two locations), Bundang, Gasan, Centum, Yangju, and Pangyo- and new AIDCs currently under construction, including those in Ulsan and Guro.
  • Kyoto Fusioneering — Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors.
Show all investments...

HB Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 9 investments in South Korea Biotechnology startups, 11 in the past 12 months

HB Investment Inc. was founded on November 11, 1999 starting with paid-in Capital of KRW 10 billion. Since its foundation, HB Investment Inc. has been investing small and medium businesses that have the potential for steady growth and profitability and helping the invested companies to grow well by giving various consulting services. As a result, HB Investment Inc. constructed comprehensive portfolio out of various industrial areas, such as game, entertainment, as well as representative high-tech industries related to semiconductor, Internet, LCD, and a smart phone, bio, health care. In addition, HB Investment Inc. has experiences in implementing business Success-fully by organizing several partnership funds for recent years.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Venture - Series Unknown, Series B, Series A
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 180
  • Round size: Series A $1.8M–$15M; Series B $3.6M–$25M; Venture - Series Unknown $941k–$23M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • IHW — iHW is an AI semiconductor company that develops ultra-low-power analog AI chips using Analog Compute-in-Memory (ACiM) technology for mobile and edge devices. The company builds analog-digital computing architectures to improve power efficiency and performance in on-device AI processing.
  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
  • Destin Power — Destin Power manufactures power conditioning products designed to improve energy management and safety. The company created the ESS system by utilizing core power electronics technology such as control technology for energy storage systems, static and dynamic grid support technology, and micro-grid inverter technology.
Show all investments...

KB Securities
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 9 investments in South Korea Biotechnology startups, 11 in the past 12 months

KB Securities is a Financial Services company.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series B, Series A, Venture - Series Unknown
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 162
  • Round size: Series A $2.4M–$11M; Series B $4.7M–$25M; Venture - Series Unknown $1.5M–$35M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Klleon — Revolutionizing AI-Human Interactions with Real-Time Digital AvatarsEstablished in 2019, Klleon pioneers a fresh dimension in AI-human relations through its real-time digital avatar video chat. Recognized by industry giants like NVIDIA, AWS, and Microsoft, Klleon's unique technologies facilitate emotionally resonant AI digital avatarinteractions. Features include rapid-response digital human animations and optimized GPT processing, ensuring efficiency in both time and cost. By creating lifelike digital avatars from just a facial snapshot and 30 seconds of voice, Klleon transcends physical, temporal, spatial, and linguistic boundaries. With Klleon, your digital twin can converse globally, anytime, in any language.
  • Liner — LINER is Asia’s first AI Agent that helps users accomplish more with less time and effort “AI Workspace”, known as the autonomous agent, performs various and complex tasks requested by users using LLM-based AI, differentiated by LINER’s highlighter database. More than 94% of LINER's users are from outside Korea & more than 100 countries.We are reducing our customer’s research time from hundreds of minutes to tens of seconds every day with our product.
  • Woori Technology — We, Woori Technology, are trying our best to satisfy customers with continuous R&D and innovation.
Show all investments...

Enlight Ventures
VC Fund · 9 investments in South Korea Biotechnology startups, 8 in the past 12 months

Enlight Ventures, one of the fastest growing VCs in the world, invests in early-stage startups with unique and sustainable business models.

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, Indonesia, United States

Investor stats

  • Total investments: 106
  • Round size: Seed $94k–$3.3M; Series A $1.8M–$14M; Series B $2.7M–$20M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • TESOLLO — Explore Tesollo multi-finger robotic grippers and dexterous robotic hands for precise manipulation, industrial automation, humanoid robotics, and Physical AI.
  • Aigencore — Aigencore is a specialized, advanced technology company focused on tritium solutions, nuclear fusion fuel cycles, and tritium-applied industrial products.
  • Stress Solution — Based on unique medical and scientific information and ECG waveforms, Stress Solution creates sound that regulates and initiates the equilibrium of the autonomic nervous system. Currently, Healing Bit is utilizing wearable technology to detect stress in real time. Through this, an autonomous feedback system that uses artificial intelligence topredict individual stress level situations and take preventative measures is being developed.
Show all investments...

Shinhan Capital
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 9 investments in South Korea Biotechnology startups

Shinhan Capital is a credit-specialized company offering corporate finance services for its clients. It provides financial services, lease, corporate loans, investment financing, housing loans, installment financing, etc. Shinhan Capital was established in 1991. The company is headquartered in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Information Technology, Software, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 215
  • Round size: Seed $424k–$4M; Series A $2.1M–$11M; Series B $4.2M–$20M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Trioar — Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.
  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
  • KB-Element — KB-Element is a graphene development and production company that also turns graphene into intermediate items and novel materials.
Show all investments...

SJ Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 8 investments in South Korea Biotechnology startups

SJ Investment Partners is a venture capital firm that invests in the IT and biotechnology industries.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Hong Kong

Investor stats

  • Total investments: 78
  • Round size: Seed $547k–$2.7M; Series A $1.6M–$12M; Series B $4.5M–$27M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • DevD — DevD is a startup that provides 1:1 customized content and recommendation services based on self-developed lifestyle AI algorithms.
  • Dnotitia — Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.
  • Eleven O'Clock — Eleven O'Clock is a space management platform that offers non-face-to-face cleaning of accommodation facilities. The company's platform Keeper innovates space operation and management as the new standard for space management. The efficiency and quality of space management are improved according to the systematic manual of the Keeperplatform. The platform records and communicates every process as data, from management manuals to space status checks.
Show all investments...

Innopolis Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 8 investments in South Korea Biotechnology startups

Innopolis Partners LLC. is a LLC-type venture capital firm in Korea. Partners of Innopolis Partners are former CEO or Representative Fund Manager of leading venture capital firms, such as Korea Technology Investment, STIC Investment, LG Venture Capital, KTB Network. “Innopolis No. 1 Fund” managed by Innopolis Partners is specialized for hi-tech startups in the Daedeok Innopolis complex. Daedeok Innopolis complex is set up based on former Daedeok R&D complex where most of major national R&D institutes, including ETRI, KAITST, KAERI, KRIBB, are located.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Venture - Series Unknown, Series A
  • Geography: South Korea, United States, United Kingdom

Investor stats

  • Total investments: 112
  • Round size: Series A $1M–$13M; Venture - Series Unknown $7.3M–$7.7M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • ABLE Labs — ABLE Labs provide liquid handling robots and protocols so that all researchers can focus on constructing assay, leaving the execution to robots.​ If you want would contact them please contact them via phone call or email.
  • AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
  • Inserasolution — Inserasolution produces high-performance Fast & Fine Steering Mirrors for laser-based space optical communications and sophisticated defense systems.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Timewise Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 8 investments in South Korea Biotechnology startups

TIMEWISE INVESTMENT, formerly known as CJ Venture Investment, is a principal investment firm specializing in investments in video broadcasting, animation, movies, culture contents, games, communications equipment, arts, sports, leisure, manufacturing and service, mobile devices and solutions, information technology, SI, web agency, cell therapy andbiotechnology sectors. The firm primarily invests in South Korea with a focus in Seoul, Gyeonggi, and Jeju. CJ Venture Investment was established in 2000 and is based in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 65
  • Round size: Seed $981k–$4.3M; Series A $1.9M–$8.7M; Series B $5.5M–$29M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Carlet Store — Carlet Bio is a wholesale supplier of packaging solutions.
  • Datumo — Datumo got your back!Obtaining the proper data has always been the top issue for many AI labs/companies. To solve this problem, Datumo provides a platform that connects your company to the crowd-workers.It's MORE than just a connection! We passionately research crowd-workers and your project to develop cutting-edge technologies forthe optimized mobile crowd-sourcing.Keep disrupting the world! Just for your project, we are here to maintain the quality, cost-efficiency, or any other burdens related to the data. Datumo was founded in 2018.
  • ProxiHealthcare USA — ProxiHealthcare USA is a biotechnology research focused personal and environmental healthcare organization.
Show all investments...

Korea Development Bank
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups, 46 in the past 12 months

The Korea Development Bank (KDB) provides long-term financing for projects designed to assist Koreaâ€:tm:s economic growth and development. It offers equipment capital loans and working capital loans to Korean private enterprises that undertake major industrial projects. The bank also extends guarantees to its clients to facilitate their other borrowings and to finance major industrial projects. KDB guarantees Won-denominated corporate debentures, local currency loans, and other Won liabilities and foreign currency loans from domestic and overseas Korean financial institutions and from foreign institutions. The bankâ€:tm:s other activities include engagement in a range of industrial development activities, including conducting economic and industrial research; performing engineering surveys; providing business analyses and managerial assistance; and offering trust services. As of June 30, 2007, KDB had 40 local branches, 6 overseas branches, and 2 overseas offices. The bank was founded in 1954 and is headquartered in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 389
  • Round size: Series A $1.9M–$26M; Series B $4.7M–$31M; Series C $7.1M–$51M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • RX — RX is a startup that provides an on-site analysis solution for material properties, mainly serving environment, energy, inspection, and testing needs. It also develops technology related to next-generation nuclear power plants and agentic AI, supported by national R&D activity.This company helps industries assess materials and engineeringconditions more efficiently and accurately.
  • Turing — Reinvent Education with Technology
  • AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
Show all investments...

Hana Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups

Hana Ventures is a corporate venture capital of Hana Financial Group.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: South Korea, United States, Indonesia

Investor stats

  • Total investments: 256
  • Round size: Seed $273k–$4.4M; Series A $1.6M–$13M; Venture - Series Unknown $882k–$11M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • BIGC — BIGC is a technology company that offers digital marketing, content creation, and advertising services.
  • Bbodek — Bbodek provider of tableware rental and washing services intended for restaurants and school cafeterias. They provide products for children's tableware and hygiene management services. They specialize in using their self-developed smart factory to render low defect services to consumers, enabling them to just focus on cooking without worryingabout cleaning up. They are expanding their business to customized washing machine manufacture and sales.
  • Welcon Systems — WELCON Systems is a company that makes electronic control equipment used in machines. Their main products include servo drives and motion controllers, which help control the movement of motors in industrial machines and robots.
Show all investments...

Dt& Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups

Dt& Investment brings the spirit of Ubuntu to the world of Venture Capital.

Show more...

Investment focus

  • Industry: Biotechnology, E-Commerce, Medical
  • Stage:Series B, Series A, Seed
  • Geography: South Korea, Vietnam, United States

Investor stats

  • Total investments: 64
  • Round size: Seed $81k–$4.5M; Series A $1.5M–$11M; Series B $4.5M–$18M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Ettifos — Ettifos provides flexible, reliable, and innovative V2X solutions to enable communication between all stakeholders on the road.
  • Inocras — Unlock the potential of a Whole Genome Sequencing Test with Inocras. Transforming diagnosis and treatment for cancer and rare diseases.
  • HANCOM InSpace — Inspace is an aerospace and geospatial intelligence company specializing in satellite ground systems and AI-based Earth observation services. It develops platforms for processing and analyzing satellite, drone, SAR, optical, and infrared imagery to support defense, environment, and commercial monitoring applications. The company also provides droneoperation systems and space data solutions, turning complex geospatial data into actionable intelligence for government and enterprise users.
Show all investments...

Stick Ventures
VC Fund · Seongnam, Kyonggi-do, South Korea · 7 investments in South Korea Biotechnology startups

Stick Ventures is a venture capital firm based in South Korea that prefers to invest in seed-stage, early-stage, and later-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States

Investor stats

  • Total investments: 51
  • Round size: Series A $2.3M–$12M; Series B $4M–$27M; Series C $16M–$122M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • HITS — HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm. The company creates a cloud-based drug development platform that connects AI models with docking and molecular dynamics.
  • DeepMetrics — AI-powered Critical Care Platform
  • Nobo Medicine — Nobo Medicine is a clinical-stage biotech company focused on developing precision therapies for blood cancers and immune-related aging diseases. It uses biomarker-driven drug discovery and translational research to identify targeted treatments, aiming to improve outcomes in oncology and age-associated immune dysfunction through innovative,data-driven biomedical approaches.
Show all investments...

Stonebridge Ventures
VC Fund · Thika, Central, Kenya · 7 investments in South Korea Biotechnology startups

Stonebridge Ventures was founded in 2008

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 36
  • Round size: Seed $1M–$2.7M; Series A $1.3M–$17M; Series B $3.5M–$15M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Hurotics — Hurotics is a company with deep-tech technology related to human-robot fusion.Hurotix's wearable robots, notably the 'H-Flex', are modular and give personalized support based on the user's demands, assisting users in overcoming physical restrictions.
  • Narnia Labs — Narnia Labs is the developer of artificial intelligence-based design software designed to provide domain-based three-dimensional synthetic data. The company's software provides design creation, evaluation, optimization, and recommendation services, enabling clients from engineering and industrial design fields to develop performance bycollaborating with AI, from manufacturing to architecture, medicine, and the metaverse.
  • Labrador Labs — LABRADOR LABS began as an academic research collaboration initiative to develop an automated analytic method for detecting both known and new vulnerabilities.
Show all investments...

HG Initiative
VC Fund · Seongdong, Kyonggi-do, South Korea · 7 investments in South Korea Biotechnology startups

HGI runs an impact-driven business, seeking to address diverse social issues through sustainable innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States

Investor stats

  • Total investments: 50
  • Round size: Seed $360k–$7.7M; Series A $1.1M–$11M; Series B $3.8M–$13M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Lumora — Lumora is an Independent Power Producer (IPP) specializing in transforming idle land into renewable energy assets by developing, owning, and operating sustainable power generation projects that maximize land value while supporting clean energy production.
  • Zari Company — Jari Company Co., Ltd.utilizes a mobile platform to computerize and process the entire process of real estate lease contract management, including issuing overdue bills, confirming monthly rent payments, and linking vacancies
  • Dolbom-ui-sin — Caregiver is a specialized platform operator that provides hospitals with advanced nursing solutions, streamlining patient care coordination, enhancing clinical workflows, and supporting specialized nursing practices through intelligent tools and integrated digital systems.
Show all investments...

Kiwoom Investment
VC Fund · Youidodong, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups, 12 in the past 12 months

Kiwoom Investment provides financial assistance with funding for small businesses.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 114
  • Round size: Series A $1.7M–$14M; Series B $4.2M–$21M; Series C $11M–$33M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • GraphAI — GraphAI AI enables seamless integration of diverse data sources for fast and user-friendly AI-powered Business Intelligence (BI).GraphAI-A leverages neural networks to maintain a comprehensive graph view and swiftly reveals valuable insights from enterprise data, facilitating trend analysis and a 360-degree customer perspective. This is achievedthrough In-DB AI technology with an intuitive low-code interface.GraphAI-T delivers accelerated and robust BI analytics by leveraging the valuable insights obtained from GraphAI-A. It further facilitates transaction processing on business data through structured queries like SQL and Cypher.
  • RX — RX is a startup that provides an on-site analysis solution for material properties, mainly serving environment, energy, inspection, and testing needs. It also develops technology related to next-generation nuclear power plants and agentic AI, supported by national R&D activity.This company helps industries assess materials and engineeringconditions more efficiently and accurately.
  • But Beautiful — A collaborative AI workspace, built on your company context. Build and orchestrate agents right alongside your team's projects, meetings, and connected apps.
Show all investments...

BSK Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups, 6 in the past 12 months

BSK Investment is a private equity investment company that invests in unlisted companies.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: South Korea

Investor stats

  • Total investments: 52
  • Round size: Series A $2.1M–$57M; Series B $5M–$26M; Series C $15M–$24M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Bunker Kids — Bunker Kids is a startup that provides solutions optimized for achieving personal health goals using data and algorithms.
  • Motif Drive — Motif Drive's platform monitors multiple vehicle and environmental parameters, applies algorithms to ensure optimal performance under varying conditions, and supports adaptive adjustments and diagnostics, enabling fleet operators and drivers to manage urban driving challenges effectively while maintaining reliability and safety on the road.
  • FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
Show all investments...

Premier Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups, 12 in the past 12 months

Premier Partners (프리미어 파트너스) is a Korean domestic funds management company. It provides investment services for individuals and businesses. Premier Partners was established in September 2005 in Seoul, Korea.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Venture - Series Unknown, Series B, Series A
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 196
  • Round size: Series A $2.6M–$15M; Series B $5.8M–$45M; Venture - Series Unknown $15M–$172M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: Likely still investing — raised $83M in 2023

Portfolio highlights

  • HITS — HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm. The company creates a cloud-based drug development platform that connects AI models with docking and molecular dynamics.
  • FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
  • Prazer Therapeutics — Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Smilegate Investment
VC Fund · Seongnam, Kyonggi-do, South Korea · 7 investments in South Korea Biotechnology startups, 27 in the past 12 months

Smilegate Investment, founded in 1999 originally as MVP Capital, is a venture capital and private equity firm that grows remarkably alongside invested companies. Since initial venture capital funding in 2000, the firm has since organized and managed more than 30 venture capital and private equity funds and has invested in more than 200 companies with promising growth potential.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 296
  • Round size: Seed $694k–$6.6M; Series A $1.4M–$15M; Series B $3.6M–$47M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • RX — RX is a startup that provides an on-site analysis solution for material properties, mainly serving environment, energy, inspection, and testing needs. It also develops technology related to next-generation nuclear power plants and agentic AI, supported by national R&D activity.This company helps industries assess materials and engineeringconditions more efficiently and accurately.
  • AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
  • Accorde Entertainment — Accorde Entertainment operates as a South Korean virtual entertainment agency.
Show all investments...

L&S Venture Capital
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups, 7 in the past 12 months

L&S Venture Capital is a venture capital firm. L&S Venture Capital is specializing in incubation, seed, early, and expansion stage investments. L&S Venture Capital invests in electronic components, including smart phones, pads, televisions and grid; telecommunications equipments; green energy sector, such as solar, wind, fuel cell, LED, and EV; machineries; broadcasting; nanotechnology; intelligent robotics; telematics; medical equipments; media contents, which inlcude creation, distribution and new media. L&S Venture Capital primarily invests in South Korea with a focus in Seoul, Gyeonggi region, and Chungnam province. L&S Venture Capital was founded in 2006 and is based in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Israel

Investor stats

  • Total investments: 118
  • Round size: Seed $692k–$5.1M; Series A $1.9M–$9.8M; Series B $4.8M–$39M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Enhans — Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services.
  • Awexome Ray — Awexome Ray is a company that manufactures next-generation X-ray generator.
  • Inserasolution — Inserasolution produces high-performance Fast & Fine Steering Mirrors for laser-based space optical communications and sophisticated defense systems.
Show all investments...

Pathfinder H
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Pathfinder H is a venture capital firm.

Show more...

Investment focus

  • Industry: E-Commerce, Biotechnology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 46
  • Round size: Seed $775k–$6M; Series A $3.3M–$13M; Series B $2.7M–$21M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Namdo Market — Namdo Market is a mobile application for wholesale and retail trading services. It is a online wholesale marketplace that connects buyers with products from major Korean shopping districts. It allows users to browse and order items directly from multiple vendors in one place.
  • Perseus — World Best Hypervisor Security Solutions for SDV
  • Camello Tech Co. — Camello Tech Co. is an agricultural products company that sells tea capsules and aloesonic pills.
Show all investments...

ActnerLab
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

ActnerLab is a venture capital and accelerator that helps hardware, IoT and biotech startups establish their initial foothold and beyond.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Venture - Series Unknown
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 110
  • Round size: Seed $37k–$84k
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • C&SR — C&SR provides expertise in research and development necessary for navigating a drug candidate through humanized animal model making/testing.
  • Chain Lightning — Chain Lightning is an electric vehicle charging station that provides electric vehicle care payment and charge management services.
  • NAiEEL Technology — NAiEEL Technology offers energy and environmental technology solutions.
Show all investments...

Coolidge Corner Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Coolidge Corner Investment (CCVC) provides Seed and Seed+ funding to the most innovative tech startup companies in Korea. They proudly provide their portfolio companies a customized support in professional incubating, growth hacking, strategy, network and more.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Belgium

Investor stats

  • Total investments: 116
  • Round size: Seed $223k–$1.5M; Series A $891k–$5.4M; Series B $7.2M–$14M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $8.9M in 2017

Portfolio highlights

  • Frefins — Frefins is a specialized Rental Transformation (RX) company that generates value by connecting businesses, financial institutions, and consumers.
  • NexThera — Nexcera provides innovative and sustainable medical solutions.
  • Plantner — PLANTNER develops environmentally friendly polymers that utilizes the controlled-release characteristics of alginate, a polymer derived from seaweed, along with natural controlled-release fertilizers to substitute current chemical products. Concurrently, the company is engaged in research and development as well as local field trials in Korea andVietnam. These innovations are directly aimed at promoting low-input sustainable agriculture. The organization is committed to tackling the unsustainable practices prevalent in conventional agriculture through the use of slow-release fertilizers, aspiring to foster eco-friendly advancements rooted in natural materials, beginning with agriculture, which is the cornerstone of the industry. In traditional agricultural settings, the significant loss of chemical fertilizers has resulted in nutrient depletion, leading to soil degradation issues such as acidification. This reduction in soil productivity compels farmers to resort to even greater quantities of chemicals to enhance yields, thereby perpetuating a detrimental cycle of increasing overuse. As a response, coated slow-release fertilizers have been introduced; however, their synthetic polymer coatings have contributed to the buildup of microplastics in the soil, harming the habitats of beneficial microorganisms and generating additional environmental challenges. To mitigate these concerns, ongoing research and development efforts are focused on substituting the conventional coating materials of slow-release fertilizers which are responsible for environmental issues like residual microplastics with alginate, a biodegradable polymer sourced from seaweed.
Show all investments...

POSCO CAPITAL
VC Fund · Yeoksamdong, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups, 7 in the past 12 months

POSCO Capital offers financial services.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States

Investor stats

  • Total investments: 98
  • Round size: Seed $171k–$6.1M; Series A $1.2M–$10M; Series B $3.7M–$14M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Leecell — Leecell is a solar cell manufacturing company that produces organic and perovskite thin‑film photovoltaic cells.
  • MID — MID specializes in the development, testing, and production of space-related components.
  • Daedong Robotics — Daedong Robotics, a Daedong Group affiliate, offers AI robot solutions that understand agricultural sites, reducing time-consuming and hazardous tasks.
Show all investments...

Shinhan Venture Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Shinhan Venture Investment operates as an investment company. Shinhan Venture Investment focuses on earlier-stage venture capital investments and later-stage control investments opportunities derived from the latest megatrends such as the aging population, disruptive technologies, IT convergence, alternative energy and etc.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Venture - Series Unknown, Series B, Series A
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 247
  • Round size: Series A $2.5M–$26M; Series B $4.5M–$45M; Venture - Series Unknown $1.7M–$78M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Return Zero — AI, ASR, Diarization, Speech, ML
  • Linq — We are creating ‘hyper-automated insurance platforms’ to comprehensively support underwriters and claim adjusters and to facilitate communication between insurers and reinsurers using AI and deep learning.
  • Inserasolution — Inserasolution produces high-performance Fast & Fine Steering Mirrors for laser-based space optical communications and sophisticated defense systems.
Show all investments...

Stone Bridge Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Stone Bridge Ventures invests in entrepreneurs with bold ideas that improve and expand people's lives, industries, and markets. They provide professional assistance and a network of contacts geared towards businesses in order to help them expand.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, South Africa

Investor stats

  • Total investments: 101
  • Round size: Seed $1.6M–$10M; Series A $2.5M–$18M; Series B $2.7M–$22M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: Likely still investing — raised $138M in 2022

Portfolio highlights

  • OQT — OQT is focusing on developing QPUs utilizing neutral atoms.
  • Enhans — Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services.
  • Amber Road — Amber Road is the creator of an operation management-focused data analysis program. By analyzing the data based on the input data, the company's platform generates a customized AI model and business insight report that requires the input of manufacturing process data.
Show all investments...

Kakao Ventures
VC Fund · Seongnam, Kyonggi-do, South Korea · 6 investments in South Korea Biotechnology startups

We are an independent subsidiary of Kakao Corp. & the most active, startup-friendly early stage VC of Korea. (Limited Partnerships, not strategic.).

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Indonesia

Investor stats

  • Total investments: 420
  • Round size: Seed $280k–$4.2M; Series A $988k–$11M; Series B $3.4M–$27M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $40B in 2025

Portfolio highlights

  • OQT — OQT is focusing on developing QPUs utilizing neutral atoms.
  • A33 Studio — A-33 Studio team is led by the chief executive officer ‘Kim Dong Sun’ who was in charge of the development, launch and operation of ‘Counter Strike Online’ which is one of the top 3 online FPS games in Korea. The team consists of developers who have worked together for ‘CS Online’ and ‘Combat Arms’ at Nexon, one of the top online game makers in theworld.
  • Tect Group — We deliver real beauty based on distinctive brands and innovative marketing solutions, fostering confidence and positivity around the world.
Show all investments...

Capstone Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups, 6 in the past 12 months

Capstone Partners is a venture capital firm specializing in early-stage companies operating in the Information technology, wireless technology, architecture, pharmaceutical, internet, online game, software, solid state disk, and IP television sectors. It primarily invests in China and South Korea, with a focus in Seoul and Gyeonggi province. The firm prefers to exit its investments through a trade sale. Capstone Partners was founded in 2008 and is based in Seoul, South Korea. Capstone Partners is a venture capital firm that invests in entrepreneurs seeking success with fresh ideas. Capstone Partners values the funds of union investors better than our own, working for the interests of investors and following the objective of the investments.

Show more...

Investment focus

  • Industry: Software, Mobile, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 311
  • Round size: Seed $223k–$3.8M; Series A $371k–$11M; Series B $914k–$17M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — raised $42M in 2019

Portfolio highlights

  • ABLE Labs — ABLE Labs provide liquid handling robots and protocols so that all researchers can focus on constructing assay, leaving the execution to robots.​ If you want would contact them please contact them via phone call or email.
  • Intellicia — AI-powered Synthetic Consumers platform for market research. 91.2% Spearman Correlation, 93.6% accuracy validated across 120+ PoC projects.
  • Wrtn Technologies — Bring AGI Close to People
Show all investments...

Biotechnology VC funding in South Korea at a glance

Stats across 1.1k deals from 723 investors.

723
investors
in South Korea Biotechnology startups
1.1k
deals
in South Korea Biotechnology startups
$4.9M
median round
in South Korea Biotechnology startups
32%
lead investors
lead at least one round
20%
Seed
most common funding stage

Access all 723 VC funds in South Korea Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in South Korea investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 723 VC funds investing in South Korea Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists